Immunotherapy Archives

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

In Depth 2 Dec 2024

The rise of cancer vaccines: A new era in immunotherapy

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.

December 2, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 31 Oct 2024

Five T cell engager companies you should know about

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

October 31, 2024 - 7 minutesmins - By Willow Shah-Neville

In Depth 30 Oct 2024

Spatial Transcriptomics: A window into disease

The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?

October 30, 2024 - 11 minutesmins - By Jonathan Smith

In Depth 30 Oct 2024

Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?

Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.

October 30, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 18 Sep 2024

Two targets, one solution: The rise of bispecific antibodies

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape looks like.

September 18, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 16 Sep 2024

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

September 16, 2024 - 6 minutesmins - By Jules Adam

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

CatalYm’s monoclonal antibody visugromab bags $150M

News and Trends 16 Jul 2024

German biotech raises $150M on its way to tackle cancer therapy resistance

On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.

July 16, 2024 - 9 minutesmins - By Jules Adam

In Depth 5 Jun 2024

Evolving standards of care: new treatments for cervical cancer

New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients.

June 5, 2024 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 May 2024

8 Swedish companies spearheading the country’s biotech scene

As Sweden’s life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry.

May 28, 2024 - 9 minutesmins - By Willow Shah-Neville

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about.

May 21, 2024 - 10 minutesmins - By Jules Adam

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Immunotherapy

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

The rise of cancer vaccines: A new era in immunotherapy

Five T cell engager companies you should know about

Spatial Transcriptomics: A window into disease

Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?

Two targets, one solution: The rise of bispecific antibodies

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

2024: a year of breakthroughs for endometrial cancer?

German biotech raises $150M on its way to tackle cancer therapy resistance

Evolving standards of care: new treatments for cervical cancer

8 Swedish companies spearheading the country’s biotech scene

Eight companies spearheading Philadelphia’s biotech industry

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!